Literature DB >> 24799195

Prosurvival function of the cellular apoptosis susceptibility/importin-α1 transport cycle is repressed by p53 in liver cancer.

Juliane Winkler1, Alessandro Ori, Kerstin Holzer, Carsten Sticht, Daniel Dauch, Eva Maria Eiteneuer, Federico Pinna, Robert Geffers, Volker Ehemann, Amparo Andres-Pons, Kai Breuhahn, Thomas Longerich, Justo Lorenzo Bermejo, Norbert Gretz, Lars Zender, Peter Schirmacher, Martin Beck, Stephan Singer.   

Abstract

UNLABELLED: Proteins of the karyopherin superfamily including importins and exportins represent an essential part of the nucleocytoplasmic transport machinery. However, the functional relevance and regulation of karyopherins in hepatocellular carcinoma (HCC) is poorly understood. Here we identified cellular apoptosis susceptibility (CAS, exportin-2) and its transport substrate importin-α1 (imp-α1) among significantly up-regulated transport factor genes in HCC. Disruption of the CAS/imp-α1 transport cycle by RNAi in HCC cell lines resulted in decreased tumor cell growth and increased apoptosis. The apoptotic phenotype upon CAS depletion could be recapitulated by direct knockdown of the X-linked inhibitor of apoptosis (XIAP) and partially reverted by XIAP overexpression. In addition, XIAP and CAS mRNA expression levels were correlated in HCC patient samples (r=0.463; P<0.01), supporting the in vivo relevance of our findings. Furthermore, quantitative mass spectrometry analyses of murine HCC samples (p53-/- versus p53+/+) indicated higher protein expression of CAS and imp-α1 in p53-/- tumors. Consistent with a role of p53 in regulating the CAS/imp-α1 transport cycle, we observed that both transport factors were repressed upon p53 induction in a p21-dependent manner.
CONCLUSION: The CAS/imp-α1 transport cycle is linked to XIAP and is required to maintain tumor cell survival in HCC. Moreover, CAS and imp-α1 are targets of p53-mediated repression, which represents a novel aspect of p53's ability to control tumor cell growth in hepatocarcinogenesis.
© 2014 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24799195     DOI: 10.1002/hep.27207

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

1.  The novel MKL target gene myoferlin modulates expansion and senescence of hepatocellular carcinoma.

Authors:  C Hermanns; V Hampl; K Holzer; A Aigner; J Penkava; N Frank; D E Martin; K C Maier; N Waldburger; S Roessler; M Goppelt-Struebe; I Akrap; A Thavamani; S Singer; A Nordheim; T Gudermann; S Muehlich
Journal:  Oncogene       Date:  2017-01-23       Impact factor: 9.867

Review 2.  Oncogenic role of p21 in hepatocarcinogenesis suggests a new treatment strategy.

Authors:  Shogo Ohkoshi; Masahiko Yano; Yasunobu Matsuda
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

3.  Cellular apoptosis susceptibility (CAS) is linked to integrin β1 and required for tumor cell migration and invasion in hepatocellular carcinoma (HCC).

Authors:  Juliane Winkler; Stephanie Roessler; Carsten Sticht; Amanda L DiGuilio; Elisabeth Drucker; Kerstin Holzer; Eva Eiteneuer; Esther Herpel; Kai Breuhahn; Norbert Gretz; Peter Schirmacher; Alessandro Ori; Stephan Singer
Journal:  Oncotarget       Date:  2016-04-19

4.  Spatial Tissue Proteomics Quantifies Inter- and Intratumor Heterogeneity in Hepatocellular Carcinoma (HCC).

Authors:  Katarzyna Buczak; Alessandro Ori; Joanna M Kirkpatrick; Kerstin Holzer; Daniel Dauch; Stephanie Roessler; Volker Endris; Felix Lasitschka; Luca Parca; Alexander Schmidt; Lars Zender; Peter Schirmacher; Jeroen Krijgsveld; Stephan Singer; Martin Beck
Journal:  Mol Cell Proteomics       Date:  2018-01-23       Impact factor: 5.911

5.  Nucleoporin Nup155 is part of the p53 network in liver cancer.

Authors:  Kerstin Holzer; Alessandro Ori; Amy Cooke; Daniel Dauch; Elisabeth Drucker; Philip Riemenschneider; Amparo Andres-Pons; Amanda L DiGuilio; Marie-Therese Mackmull; Jochen Baßler; Stephanie Roessler; Kai Breuhahn; Lars Zender; Joseph S Glavy; Frank Dombrowski; Ed Hurt; Peter Schirmacher; Martin Beck; Stephan Singer
Journal:  Nat Commun       Date:  2019-05-14       Impact factor: 14.919

6.  KPNA2 promotes renal cell carcinoma proliferation and metastasis via NPM.

Authors:  Song Zheng; Xiaofan Li; Ting Deng; Rong Liu; Junjie Bai; Teng Zuo; Yinan Guo; Jianhui Chen
Journal:  J Cell Mol Med       Date:  2021-09-01       Impact factor: 5.310

7.  CSE1L participates in regulating cell mitosis in human seminoma.

Authors:  Chunyan Liu; Jiajing Wei; Kang Xu; Xiaosong Sun; Huiping Zhang; Chengliang Xiong
Journal:  Cell Prolif       Date:  2018-11-28       Impact factor: 6.831

8.  Prognostic roles of the transcriptional expression of exportins in hepatocellular carcinoma.

Authors:  Lubiao Chen; Yanlin Huang; Liang Zhou; Yifan Lian; Jialiang Wang; Dongmei Chen; Huan Wei; Mingsheng Huang; Yuehua Huang
Journal:  Biosci Rep       Date:  2019-08-19       Impact factor: 3.840

9.  Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer.

Authors:  Elisabeth Drucker; Kerstin Holzer; Stefan Pusch; Juliane Winkler; Diego F Calvisi; Eva Eiteneuer; Esther Herpel; Benjamin Goeppert; Stephanie Roessler; Alessandro Ori; Peter Schirmacher; Kai Breuhahn; Stephan Singer
Journal:  Cell Commun Signal       Date:  2019-11-29       Impact factor: 5.712

10.  HELLS Is Negatively Regulated by Wild-Type P53 in Liver Cancer by a Mechanism Involving P21 and FOXM1.

Authors:  Stefanie Schuller; Jan Sieker; Philip Riemenschneider; Bianca Köhler; Elisabeth Drucker; Sofia M E Weiler; Daniel Dauch; Carsten Sticht; Benjamin Goeppert; Stephanie Roessler; Silvia Ribback; Kai Breuhahn; Falko Fend; Frank Dombrowski; Kerstin Singer; Stephan Singer
Journal:  Cancers (Basel)       Date:  2022-01-17       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.